Clinical Trials
284
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (180 trials with phase data)• Click on a phase to view related trials
PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2)MethylphenidateObesity &Amp; Overweight
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 30
- Registration Number
- NCT07121621
- Locations
- 🇫🇷
Center Hospitalier Régional Universitaire of TOURS, Tours, Indre-et-Loire, France
Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients
- Conditions
- Chronic Kidney Disease Requiring Hemodialysis
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 80
- Registration Number
- NCT07054112
- Locations
- 🇫🇷
CH Angers, Angers, France
🇫🇷CH Bayonne, Bayonne, France
🇫🇷CHRU de Bordeaux, Bordeaux, France
Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study
- Conditions
- Lung Cancer (NSCLC)
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 150
- Registration Number
- NCT07004868
- Locations
- 🇫🇷
university hospital, Tours, Tours, France
Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
- Conditions
- Community-acquired Pneumonia
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 1078
- Registration Number
- NCT06966310
- Locations
- 🇫🇷
Intensive care, University Hospital, Amiens, Amiens, France
🇫🇷Intensive care, University Hospital, Angers, Angers, France
🇫🇷Intensive care, University Hospital, Argenteuil, Argenteuil, France
Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis (RA)
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 30
- Registration Number
- NCT06933134
- Locations
- 🇫🇷
University hospital, Tours, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 57
- Next